Drug
Pramlintide clinical trials
Also written Symlin.
- studies test it
- 43
- open now
- 1
- in phase 3
- 8
- first study started
- 2002
Keep track of what changes. Save the pramlintide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
- Symlin
- 14
Studies by the year they started
43 studies that test it; most in 2002 (6)
| Year | Studies |
|---|---|
| 2002 | 6 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 3
- Phase 2
- 16
- Phase 3
- 8
- Phase 4
- 10
- No phase
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 21 · Other 22
AstraZeneca (19) · Baylor College of Medicine (4) · McGill University Health Centre/Research Institute of the McGill University Health Centre (2) · University of Texas Southwestern Medical Center (2) · University of Colorado, Denver (2) · Boston University (1) · Xeris Pharmaceuticals (1) · Joslin Diabetes Center (1)
Often tested with
Tested in the same studies.
Metreleptin (4) · Insulin (2) · Exenatide (2) · Insulin Aspart (1) · Glucagon (1) · Sibutramine (1) · Phentermine (1) · Leptin (1)
Studies
Open first, then newest update. How each study uses pramlintide is read from its arms, and is right about nine times in ten.
Testing it · 43
- A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 DiabetesRecruitingPhase 2/3McGill University Health Centre/Research Institute of the McGill University Health CentreNCT06046417Written as Pramlintide
- Multi-Center Development of a Novel Diagnostic Test for Alzheimer's DiseaseActive, not recruitingEarly Phase 1Boston UniversityNCT03560960Written as Pramlintide challenge test
- Tailoring Obesity Treatment TrialWithdrawnPhase 2/3Esbjerg Hospital - University Hospital of Southern DenmarkNCT06619015Written as Pramlintide Acetate 1 MG/ML
- Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1DCompletedPhase 2Xeris PharmaceuticalsNCT04074317Written as Regular Insulin + Pramlintide
- A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 DiabetesCompletedNot applicableMcGill University Health Centre/Research Institute of the McGill University Health CentreNCT05199714Written as Pramlintide
- Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass SurgeryCompletedPhase 4Joslin Diabetes CenterNCT01841359Written as Pramlintide
- Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot StudyWithdrawnEarly Phase 1H. Lee Moffitt Cancer Center and Research InstituteNCT04252612Written as Pramlintide
- Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 DiabetesStatus unknownNot applicableMcGill UniversityNCT04243629Written as Pramlintide Acetate
- A Study of the Functional Magnetic Resonance Imaging Response to Leptin and PramlintideStatus unknownNot applicableOregon Health and Science UniversityNCT00691158Written as Pramlintide (Amylin)
- Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DMWithdrawnNot applicableUniversity of Maryland, BaltimoreNCT00732147Written as Pramlintide acetate
- Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 DiabetesWithdrawnPhase 4University of Texas Southwestern Medical CenterNCT00505882Written as Pramlintide
- Demonstrate the Effects of Pramlintide on Weight Reduction in SchizophreniaCompletedPhase 4University of Texas Southwestern Medical CenterNCT00690235Written as Pramlintide
- Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes MellitusCompletedPhase 1AstraZenecaNCT02500979Written as Pramlintide acetate
- Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes MellitusWithdrawnPhase 1/2University of Colorado, DenverNCT01165944Written as Pramlintide
- Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes MellitusCompletedPhase 4Montefiore Medical CenterNCT00442767Written as Pramlintide + Insulin
- Use of Exenatide and Pramlintide to Decrease Post-prandial HyperglycemiaCompletedPhase 4Albert Einstein College of MedicineNCT01269047Written as Pramlintide
- The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 DiabetesCompletedPhase 4Baylor College of MedicineNCT00950677Written as Symlin (pramlintide)
- The Role of Amylin and Glucagon in T1DMCompletedPhase 3Baylor College of MedicineNCT00206258Written as Pramlintide and glucagon
- Continuous Subcutaneous Infusion of Pramlintide and InsulinCompletedPhase 4Baylor College of MedicineNCT00291772Written as Pramlintide
- The Effect of Prolonged Pramlintide Infusion in Pediatric DiabetesCompletedPhase 3Baylor College of MedicineNCT00206297Written as Pramlintide
See all 43 studies that test pramlintide →
As the comparator · 3 — what is tested is compared with pramlintide
- Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial PancreasCompletedNot applicableMcGill UniversityNCT04163874Written as Pramlintide Acetate
- A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes MellitusCompletedPhase 1AdociaNCT03916640Written as Symlin®
- A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes MellitusCompletedPhase 1AdociaNCT03512236Written as Symlin® and Humulin®
Codes
What other systems call pramlintide · ClinicalTrials.gg INT003976
- MeSH (NLM) C105254pramlintideConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) D3FM8FA78TPRAMLINTIDEConfirmed FDA, NLM
- RxNorm 139953One source FDA
- NCI Thesaurus C61901PramlintideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C105254 | pramlintide | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | D3FM8FA78T | PRAMLINTIDE | Confirmed FDA, NLM |
| RxNorm | 139953 | — | One source FDA |
| NCI Thesaurus | C61901 | Pramlintide | One source FDA |
Also registered as pramlintide acetate (UNII 726I6TE06G · RxNorm 356773).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.